SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-153425
Filing Date
2021-05-06
Accepted
2021-05-06 16:59:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d923868ddefa14a.htm DEFA14A 16907
2 GRAPHIC g923868allena.jpg GRAPHIC 14692
3 GRAPHIC g923868brennersig.jpg GRAPHIC 2871
  Complete submission text file 0001193125-21-153425.txt   42417
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38268 | Film No.: 21898740
SIC: 2836 Biological Products, (No Diagnostic Substances)